Apoptotic cascade inspired lipid nanovesicles show synergism with encapsulated paclitaxel in chemoresistant colon carcinoma
DSpace at IIT Bombay
View Archive InfoField | Value | |
Title |
Apoptotic cascade inspired lipid nanovesicles show synergism with encapsulated paclitaxel in chemoresistant colon carcinoma
|
|
Creator |
JOSHI, N
SHANMUGAM, T DESHMUKH, A BANERJEE, R |
|
Subject |
colon carcinoma
drug resistance lipid nanovesicles paclitaxel phosphatidylserine proapoptotic P-GLYCOPROTEIN BREAST-CANCER DRUG-RESISTANCE CYTOCHROME-C IN-VIVO CELLS LIPOSOMES PHOSPHATIDYLSERINE NANOPARTICLES PROTEIN |
|
Description |
Inspired from the apoptotic cascade, we developed phosphatidylserine (PS)-based proapoptotic lipid nanovesicles, capable of bypassing drug resistance and exhibiting synergistic anticancer activity with encapsulated paclitaxel in chemoresistant human colon adenocarcinoma (HCT-15). Materials & methods: Nanovesicles were developed and evaluated both in vitro and in vivo for their proapoptotic activity, synergism with encapsulated paclitaxel and ability to bypass drug resistance. Results: 110 +/- 7 nm sized nanovesicles were found to be proapoptotic and synergistic with paclitaxel, and bypassed drug resistance. The formulation, with synergistic inputs from PS and paclitaxel, downregulated Ki-67 and inhibited angiogenesis leading to apoptosis by activating caspase-3 and downregulating Bcl-2, resulting in DNA fragmentation. The nanovesicles, while increasing the systemic circulation time of paclitaxel by 6.9-fold reduced systemic toxic effects of paclitaxel and were found to be nonimmunogenic. Conclusion: These results suggest the therapeutic potential of PS-based proapoptotic nanovesicles encapsulating paclitaxel in chemoresistant human colon carcinoma.
|
|
Publisher |
FUTURE MEDICINE LTD
|
|
Date |
2014-12-28T15:03:54Z
2014-12-28T15:03:54Z 2014 |
|
Type |
Article
|
|
Identifier |
NANOMEDICINE, 9(12)1789-1805
1743-5889 1748-6963 http://dx.doi.org/10.2217/NNM.13.182 http://dspace.library.iitb.ac.in/jspui/handle/100/16824 |
|
Language |
English
|
|